IN PATIENTS WITH CANCER

Chapter 082. Infections in Patients with Cancer (Part 10) Renal and Ureteral Infections Infections of the urinary tract are common among patients whose ureteral excretion is compromised (Table 82-1). Candida, which has a predilection for the kidney, can invade eit[r]

Chapter 082. Infections in Patients with Cancer (Part 3) The level of suspicion of infections with certain organisms should depend on the type of cancer diagnosed (Table 82-3). Diagnosis of multiple myeloma or CLL should alert the clinician to the possibil[r]

Chapter 082. Infections in Patients with Cancer (Part 8) Brain Masses Mass lesions of the brain most often present as headache with or without fever or neurologic abnormalities. Infections associated with mass lesions may be caused by bacteria (particularly[r]

Chapter 082. Infections in Patients with Cancer (Part 4) Figure 82-1 A. Papules related to Escherichia coli bacteremia in a neutropenic patient with acute lymphocytic leukemia. B. The same lesion the following day. Candidemia (Chap. 196) is also associated[r]

Patients with cancer have an increased risk of malnutrition which is associated with poor outcome. The Mini Nutritional Assessment (MNA®) is often used in older patients with cancer but its relation to outcome is not known.

Distress in patients with cancer influences their quality of life. Worldwide, screening on distress with the Distress Thermometer (DT) in patients with cancer is recommended. However, the effects of the use of the DT on the psychosocial wellbeing of the patient are unknown.

etiology of thrombocytosis has not been established in most cases. Patients with thrombocytosis are nearly all asymptomatic. Thrombocytosis is not clearly linked to thrombosis in patients with cancer. Thrombocytosis is present in 40% of pati[r]

Patients with advanced stage non-small cell lung cancer (NSCLC) or small cell lung cancer (SCLC) often experience multidimensional impairments, affecting quality of life during their course of disease. In lung cancer patients with operable disease, several studies have shown that exercise has a posi[r]

To study the association between Apelin expression and the clinical features and postoperative prognosis in patients with gastric cancer (Int J Cancer 136:2388-2401, 2015). Methods: Tumor samples and matched adjacent normal tissues were collected from 270 patients with GC receiving surgical resectio[r]

Mediastinal lymph node metastases occasionally occur in patients of advanced gastric cancer of the cardia with esophageal invasion, but they rarely occur in patients with gastric cancer of other sites.

The survival of patients with ovarian cancer has improved because of surgery and chemotherapy. This study aimed to estimate the changes in survival rates among Korean women with ovarian cancer prior to the introduction of targeted therapy for ovarian cancer.

Bladder cancer is the 7th cause of death from cancer in men and 10th in women. Metastatic patients have a poor prognosis with a median overall survival of 14 months. Until recently, vinflunine was the only secondline chemotherapy available for patients who relapse.

Neoadjuvant chemotherapy (NAC) is extensively used in the treatment of patients with gastric cancer (GC), particularly in high risk, advanced gastric cancer. Previous trials testing the efficacy of NAC have reported inconsistent results.

: Patients diagnosed with metastatic castration-refractory prostate cancer (mCRPC) rely on a limited number of therapeutic agents resulting in a median survival of 2–3 years. A subgroup of those patients with mCRPC presents with oligoprogressive disease.

for benign apocrine metaplasias. These studies have also presentedcompelling evidence for a direct link, through the expression of15-PGDH, between early apocrine lesions and pure apocrine carci-nomas. Moreover, specific antibodies against components of thesignature have identified precursor lesions

Xem Thêm " SALIVARY LEVELS OF CARIOGENIC BACTERIA IN PATIENTS TREATED WITH SELF LIGATING AND CONVENTIONAL BRACKETS "

Xem Thêm " SSCP ANALYSIS FOR THE DETECTION OF MUTATIONS IN TUMOR TISSUE SAMPLES "